Michael R. Dougherty has served on our Board since February 2017.

Mr. Dougherty has over 35 years of experience in the pharmaceutical industry, most recently serving as executive chairman of Celator Pharmaceuticals, Inc. He previously held a number of senior positions in the industry, including chief executive officer of Kalidex Pharmaceuticals, Inc., president and chief executive officer at Adolor Corporation, president and chief operating officer of Genomics Collaborative, Inc., president and chief executive office at Genaera Corporation, and chief financial officer at Centocor, Inc.

Mr. Dougherty is currently on the board of directors at Trevena, Inc. and Idera Pharmaceuticals, Inc., and previously served as a member of the boards of directors of Foundation Medicine, Inc., Aviragen Therapeutics, Cempra, Inc., and Viropharma Incorporated. He received a bachelor’s degree in accounting from Villanova University.